Piotr Szychowiak
Overview
Explore the profile of Piotr Szychowiak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
dHumieres C, Haviari S, Petitjean M, Deconinck L, Gueye S, Peiffer-Smadja N, et al.
Int J Med Microbiol
. 2025 Feb;
318:151650.
PMID: 39938404
Background: Currently, diagnosis of bacterial infections is based on culture, possibly followed by the amplification and sequencing (Sanger method) of the 16S rDNA - encoding gene when cultures are negative....
2.
Szychowiak P, Boulain T, Timsit J, Elabbadi A, Argaud L, Ehrmann S, et al.
Ann Intensive Care
. 2024 Feb;
14(1):27.
PMID: 38353928
No abstract available.
3.
Szychowiak P, Boulain T, Timsit J, Elabbadi A, Argaud L, Ehrmann S, et al.
Ann Intensive Care
. 2023 Aug;
13(1):74.
PMID: 37608140
Background: Both AIDS-defining and non-AIDS-defining cancers (ADC/NADC) predispose people living with HIV (PLHIV) to critical illnesses. The objective of this multicentre study was to investigate the prognostic impact of ADC...
4.
Patrier J, Villageois-Tran K, Szychowiak P, Ruckly S, Gschwind R, Wicky P, et al.
Crit Care
. 2022 Oct;
26(1):300.
PMID: 36192756
Background: The composition of the digestive microbiota may be associated with outcome and infections in patients admitted to the intensive care unit (ICU). The dominance by opportunistic pathogens (such as...
5.
Szychowiak P, Desgrouas M, Ehrmann S
Infect Dis Now
. 2022 May;
52(6):327-333.
PMID: 35537688
Administration of inhaled antibiotics in intensive care units (ICU) remains confidential compared to bronchodilators, not withstanding extensive pre-clinical and clinical research and potential indications associated with the emergence of bacterial...
6.
Szychowiak P, Villageois-Tran K, Patrier J, Timsit J, Ruppe E
Ann Intensive Care
. 2022 Jan;
12(1):3.
PMID: 34985651
The composition of the gut microbiota is highly dynamic and changes according to various conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence knowledge about its composition has significantly...
7.
Lombardi Y, Azoyan L, Szychowiak P, Bellamine A, Lemaitre G, Bernaux M, et al.
Intensive Care Med
. 2021 Sep;
47(12):1426-1439.
PMID: 34585270
Purpose: The Coronavirus disease 2019 (COVID-19) has led to an unparalleled influx of patients. Prognostic scores could help optimizing healthcare delivery, but most of them have not been comprehensively validated....
8.
Lascarrou J, Gaultier A, Soumagne T, Serck N, Sauneuf B, Piagnerelli M, et al.
Front Med (Lausanne)
. 2021 Mar;
8:632933.
PMID: 33777977
Different phenotypes have been identified in acute respiratory distress syndrome (ARDS). Existence of several phenotypes in coronavirus disease (COVID-19) related acute respiratory distress syndrome is unknown. We sought to identify...
9.
Szychowiak P, Gensburger S, Bocar T, Landel C, Philippe M, Le Pennec D, et al.
J Aerosol Med Pulm Drug Deliv
. 2021 Mar;
34(5):303-310.
PMID: 33761286
Obstructive patients may benefit from nasal high-flow (NHF) therapy, but the use of pressurized metered-dose inhalers (pMDIs) has not been evaluated in this situation. Using an adult circuit and medium-sized...
10.
Grimaldi D, Aissaoui N, Blonz G, Carbutti G, Courcelle R, Gaudry S, et al.
Ann Intensive Care
. 2020 Oct;
10(1):131.
PMID: 33025225
Background: Limited data are available regarding antiviral therapy efficacy in most severe patients under mechanical ventilation for Covid-19-related acute respiratory distress syndrome (ARDS). Methods: Comparison of antiviral strategies (none, hydroxychloroquine...